The COVID-19 pandemic continues to impact people, our economy, and our health and social systems. Until we have a vaccine, research and testing are key.
McMaster HealthLabs (MHL) was created to respond to this urgent need. Under the leadership of CEO John Gilmour, MHL is working with a team of scientists and doctors from McMaster University, the Research Institute of St. Joseph’s Hamilton and other Canadian universities and research organizations to generate the scientific data critical to developing innovative ways to keep Canadians safe and to support a strong economy. Dr. Jack Gauldie, Vice President (Research) at St. Joseph’s Healthcare Hamilton, and Dr. Marek Smieja, Microbiologist and Professor, Pathology and Molecular Medicine at McMaster University helped bring together some of the brightest minds to create MHL.
MHL is a non-profit organization. We have partnerships and research initiatives with large health care and manufacturing organizations, and an important study supported by Air Canada
and The Greater Toronto Airports Authority
. Our aim is to help Canadian businesses create safe places of work through operational research and delivery of COVID-19 testing.